Belite Bio (BLTE) Tops Q2 EPS by 8c
Belite Bio (NASDAQ: BLTE) reported Q2 EPS of ($0.31), $0.08 better than the analyst estimate of ($0.39).
For earnings history and earnings-related data on Belite Bio (BLTE) click here.
Belite Bio (NASDAQ: BLTE) reported Q2 EPS of ($0.31), $0.08 better than the analyst estimate of ($0.39).
For earnings history and earnings-related data on Belite Bio (BLTE) click here.